packageBetibeglogeneAutotemcel

betibeglogene autotemcel

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Betibeglogene autotemcel is a gene therapy used to treat beta-thalassemia. It is an approved medicine, authorised in the European Union as a hematological agent.

Summary written by glm-5.3-flash from Wikidata Q24975367 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:betibeglogene autotemcel
ATC codes:B06AX02
DrugBank:DB16900
Wikidata:Q24975367

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown